SmofKabiven® Low Osmo Peripheral

(amino acids, electrolytes, glucose, lipid emulsion)

For GB healthcare professionals only. This content contains promotional and brand information.
 
Scroll down for prescribing information for multi-chamber bag products and further product information. Adverse event reporting details are available at the bottom of this webpage.
 
For more product information and resources for Fresenius Kabi's multi-chamber bags, visit: multichamberbags.co.uk
 
Multi-chamber bags for parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient, or contraindicated.
 
PN should be monitored, and doses adjusted according to individual patient response. Please refer to the Summary of Product Characteristics before prescribing.

Please note product image is for illustrative purposes only and labelling on actual product may appear differently.

Filename
Multi-Chamber Bag Prescribing Information.pdf
Size
167 KB
Format
pdf
Multi-Chamber Bag Prescribing Information.pdf
Filename
Macronutrient Prescribing Information.pdf
Size
209 KB
Format
pdf
Macronutrient Prescribing Information.pdf

Details

 

  • Contains the 4-oil mix SMOFlipid® (soya-bean oil, medium-chain triglycerides, olive oil and fish oil) - see macronutrient prescribing information above
  • Approximate osmolarity of 750 mosmol/l 
  • Contains taurine in the amino acid solution
  • Shelf life of this product as packaged for sale (unmixed): 2 years

  • Has a protein-energy ratio: 1g amino acids/29kcal*
  • Three chamber bag
  • For peripheral or central venous administration
       *Figures are approximate

       

 

Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated. 

Order Code ProductPresentation size Pack qty 
833111220SmofKabiven® Low Osmo Peripheral 6gN1400 ml4
833129220SmofKabiven® Low Osmo Peripheral 8gN1950 ml4
833137220SmofKabiven® Low Osmo Peripheral 10gN2500 ml3

gN = grams of nitrogen


Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited.  Email: Pharmacovigilance.GB@fresenius-kabi.com

GB-SKLO-2400003 January 2025

By entering the Healthcare Professional Area you are confirming you are a GB Healthcare Professional. This area contains promotional information. If you are not a Healthcare Professional you will be directed to the Fresenius Kabi GB Corporate website.

GB-NP-2400163 October 2024